What are semaglutide and tirzepatide?
Semaglutide, recognized as a glucagon-like peptide receptor agonist (GLP-1 RA), is the active ingredient in Wegovy®, a popular injectable medication that is FDA-approved for long-term weight management.
Tirzepatide is recognized as both a glucagon-like peptide receptor agonist (GLP-1 RA) and glucose-dependent insulinotropic peptide (GIP). This dual medication is the active ingredient in Zepbound®, which is also FDA-approved for long-term weight management.
Our Medical Wellness Program uses semaglutide or tirzepatide when clinically appropriate – combined with diet, exercise, and a healthy lifestyle – to help our patients achieve their wellness and weight loss goals.
Semaglutide vs. tirzepatide: What’s the difference?
Both semaglutide and tirzepatide mimic GLP-1, a natural hormone in your intestines that plays a critical role in controlling blood sugar levels after you eat. In addition, tirzepatide also mimics the GIP hormone, which is known to trigger insulin secretion and feelings of fullness. Ask your board-certified and licensed medical professional about the other important health benefits these medications can provide.
You can trust our team of board-certified and licensed specialists to guide you through your journey to better health by offering constant monitoring and support. You will receive a customized plan, beginning with a detailed medical assessment which guides your individualized road to wellness.